Cardioprotection by resveratrol: A novel mechanism via autophagy involving the mTORC2 pathway

Narasimman Gurusamy, I. Lekli, Subhendu Mukherjee, Diptarka Ray, Md Kaimul Ahsan, Mihaela Gherghiceanu, Lawrence M. Popescu, Dipak K. Das

Research output: Contribution to journalArticle

185 Citations (Scopus)

Abstract

Aims: On the basis of our previous reports that cardioprotection induced by ischaemic preconditioning induces autophagy and that resveratrol, a polyphenolic antioxidant present in grapes and red wine induces preconditioning-like effects, we sought to determine if resveratrol could induce autophagy. Methods and results: Resveratrol at lower doses (0.1 and 1 μM in H9c2 cardiac myoblast cells and 2.5 mg/kg/day in rats) induced cardiac autophagy shown by enhanced formation of autophagosomes and its component LC3-II after hypoxia-reoxygenation or ischaemia-reperfusion. The autophagy was attenuated with the higher dose of resveratrol. The induction of autophagy was correlated with enhanced cell survival and decreased apoptosis. Treatment with rapamycin (100 nM), a known inducer of autophagy, did not further increase autophagy compared with resveratrol alone. Autophagic inhibitors, wortmannin (2 μM) and 3-methyladenine (10 mM), significantly attenuated the resveratrol-induced autophagy and induced cell death. The activation of mammalian target of rapamycin (mTOR) was differentially regulated by low-dose resveratrol, i.e. the phosphorylation of mTOR at serine 2448 was inhibited, whereas the phosphorylation of mTOR at serine 2481 was increased, which was attenuated with a higher dose of resveratrol. Although resveratrol attenuated the activation of mTOR complex 1, low-dose resveratrol significantly induced the expression of Rictor, a component of mTOR complex 2, and activated its downstream survival kinase Akt (Ser 473). Resveratrol-induced Rictor was found to bind with mTOR. Furthermore, treatment with Rictor siRNA attenuated the resveratrol-induced autophagy. Conclusion: Our results indicate that at lower dose, resveratrol-mediated cell survival is, in part, mediated through the induction of autophagy involving the mTOR-Rictor survival pathway.

Original languageEnglish
Pages (from-to)103-112
Number of pages10
JournalCardiovascular Research
Volume86
Issue number1
DOIs
Publication statusPublished - Apr 2010

Fingerprint

Autophagy
Sirolimus
resveratrol
TOR complex 2
Serine
Cardiac Myoblasts
Cell Survival
Phosphorylation
Ischemic Preconditioning
Vitis
Wine
Small Interfering RNA
Reperfusion
Cell Death
Phosphotransferases
Ischemia
Antioxidants

Keywords

  • Autophagy
  • Cardioprotection
  • Cell survival
  • mTOR
  • Resveratrol
  • Rictor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Physiology

Cite this

Gurusamy, N., Lekli, I., Mukherjee, S., Ray, D., Ahsan, M. K., Gherghiceanu, M., ... Das, D. K. (2010). Cardioprotection by resveratrol: A novel mechanism via autophagy involving the mTORC2 pathway. Cardiovascular Research, 86(1), 103-112. https://doi.org/10.1093/cvr/cvp384

Cardioprotection by resveratrol : A novel mechanism via autophagy involving the mTORC2 pathway. / Gurusamy, Narasimman; Lekli, I.; Mukherjee, Subhendu; Ray, Diptarka; Ahsan, Md Kaimul; Gherghiceanu, Mihaela; Popescu, Lawrence M.; Das, Dipak K.

In: Cardiovascular Research, Vol. 86, No. 1, 04.2010, p. 103-112.

Research output: Contribution to journalArticle

Gurusamy, N, Lekli, I, Mukherjee, S, Ray, D, Ahsan, MK, Gherghiceanu, M, Popescu, LM & Das, DK 2010, 'Cardioprotection by resveratrol: A novel mechanism via autophagy involving the mTORC2 pathway', Cardiovascular Research, vol. 86, no. 1, pp. 103-112. https://doi.org/10.1093/cvr/cvp384
Gurusamy, Narasimman ; Lekli, I. ; Mukherjee, Subhendu ; Ray, Diptarka ; Ahsan, Md Kaimul ; Gherghiceanu, Mihaela ; Popescu, Lawrence M. ; Das, Dipak K. / Cardioprotection by resveratrol : A novel mechanism via autophagy involving the mTORC2 pathway. In: Cardiovascular Research. 2010 ; Vol. 86, No. 1. pp. 103-112.
@article{8bbc728539da406ea967653ff60f7a16,
title = "Cardioprotection by resveratrol: A novel mechanism via autophagy involving the mTORC2 pathway",
abstract = "Aims: On the basis of our previous reports that cardioprotection induced by ischaemic preconditioning induces autophagy and that resveratrol, a polyphenolic antioxidant present in grapes and red wine induces preconditioning-like effects, we sought to determine if resveratrol could induce autophagy. Methods and results: Resveratrol at lower doses (0.1 and 1 μM in H9c2 cardiac myoblast cells and 2.5 mg/kg/day in rats) induced cardiac autophagy shown by enhanced formation of autophagosomes and its component LC3-II after hypoxia-reoxygenation or ischaemia-reperfusion. The autophagy was attenuated with the higher dose of resveratrol. The induction of autophagy was correlated with enhanced cell survival and decreased apoptosis. Treatment with rapamycin (100 nM), a known inducer of autophagy, did not further increase autophagy compared with resveratrol alone. Autophagic inhibitors, wortmannin (2 μM) and 3-methyladenine (10 mM), significantly attenuated the resveratrol-induced autophagy and induced cell death. The activation of mammalian target of rapamycin (mTOR) was differentially regulated by low-dose resveratrol, i.e. the phosphorylation of mTOR at serine 2448 was inhibited, whereas the phosphorylation of mTOR at serine 2481 was increased, which was attenuated with a higher dose of resveratrol. Although resveratrol attenuated the activation of mTOR complex 1, low-dose resveratrol significantly induced the expression of Rictor, a component of mTOR complex 2, and activated its downstream survival kinase Akt (Ser 473). Resveratrol-induced Rictor was found to bind with mTOR. Furthermore, treatment with Rictor siRNA attenuated the resveratrol-induced autophagy. Conclusion: Our results indicate that at lower dose, resveratrol-mediated cell survival is, in part, mediated through the induction of autophagy involving the mTOR-Rictor survival pathway.",
keywords = "Autophagy, Cardioprotection, Cell survival, mTOR, Resveratrol, Rictor",
author = "Narasimman Gurusamy and I. Lekli and Subhendu Mukherjee and Diptarka Ray and Ahsan, {Md Kaimul} and Mihaela Gherghiceanu and Popescu, {Lawrence M.} and Das, {Dipak K.}",
year = "2010",
month = "4",
doi = "10.1093/cvr/cvp384",
language = "English",
volume = "86",
pages = "103--112",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Cardioprotection by resveratrol

T2 - A novel mechanism via autophagy involving the mTORC2 pathway

AU - Gurusamy, Narasimman

AU - Lekli, I.

AU - Mukherjee, Subhendu

AU - Ray, Diptarka

AU - Ahsan, Md Kaimul

AU - Gherghiceanu, Mihaela

AU - Popescu, Lawrence M.

AU - Das, Dipak K.

PY - 2010/4

Y1 - 2010/4

N2 - Aims: On the basis of our previous reports that cardioprotection induced by ischaemic preconditioning induces autophagy and that resveratrol, a polyphenolic antioxidant present in grapes and red wine induces preconditioning-like effects, we sought to determine if resveratrol could induce autophagy. Methods and results: Resveratrol at lower doses (0.1 and 1 μM in H9c2 cardiac myoblast cells and 2.5 mg/kg/day in rats) induced cardiac autophagy shown by enhanced formation of autophagosomes and its component LC3-II after hypoxia-reoxygenation or ischaemia-reperfusion. The autophagy was attenuated with the higher dose of resveratrol. The induction of autophagy was correlated with enhanced cell survival and decreased apoptosis. Treatment with rapamycin (100 nM), a known inducer of autophagy, did not further increase autophagy compared with resveratrol alone. Autophagic inhibitors, wortmannin (2 μM) and 3-methyladenine (10 mM), significantly attenuated the resveratrol-induced autophagy and induced cell death. The activation of mammalian target of rapamycin (mTOR) was differentially regulated by low-dose resveratrol, i.e. the phosphorylation of mTOR at serine 2448 was inhibited, whereas the phosphorylation of mTOR at serine 2481 was increased, which was attenuated with a higher dose of resveratrol. Although resveratrol attenuated the activation of mTOR complex 1, low-dose resveratrol significantly induced the expression of Rictor, a component of mTOR complex 2, and activated its downstream survival kinase Akt (Ser 473). Resveratrol-induced Rictor was found to bind with mTOR. Furthermore, treatment with Rictor siRNA attenuated the resveratrol-induced autophagy. Conclusion: Our results indicate that at lower dose, resveratrol-mediated cell survival is, in part, mediated through the induction of autophagy involving the mTOR-Rictor survival pathway.

AB - Aims: On the basis of our previous reports that cardioprotection induced by ischaemic preconditioning induces autophagy and that resveratrol, a polyphenolic antioxidant present in grapes and red wine induces preconditioning-like effects, we sought to determine if resveratrol could induce autophagy. Methods and results: Resveratrol at lower doses (0.1 and 1 μM in H9c2 cardiac myoblast cells and 2.5 mg/kg/day in rats) induced cardiac autophagy shown by enhanced formation of autophagosomes and its component LC3-II after hypoxia-reoxygenation or ischaemia-reperfusion. The autophagy was attenuated with the higher dose of resveratrol. The induction of autophagy was correlated with enhanced cell survival and decreased apoptosis. Treatment with rapamycin (100 nM), a known inducer of autophagy, did not further increase autophagy compared with resveratrol alone. Autophagic inhibitors, wortmannin (2 μM) and 3-methyladenine (10 mM), significantly attenuated the resveratrol-induced autophagy and induced cell death. The activation of mammalian target of rapamycin (mTOR) was differentially regulated by low-dose resveratrol, i.e. the phosphorylation of mTOR at serine 2448 was inhibited, whereas the phosphorylation of mTOR at serine 2481 was increased, which was attenuated with a higher dose of resveratrol. Although resveratrol attenuated the activation of mTOR complex 1, low-dose resveratrol significantly induced the expression of Rictor, a component of mTOR complex 2, and activated its downstream survival kinase Akt (Ser 473). Resveratrol-induced Rictor was found to bind with mTOR. Furthermore, treatment with Rictor siRNA attenuated the resveratrol-induced autophagy. Conclusion: Our results indicate that at lower dose, resveratrol-mediated cell survival is, in part, mediated through the induction of autophagy involving the mTOR-Rictor survival pathway.

KW - Autophagy

KW - Cardioprotection

KW - Cell survival

KW - mTOR

KW - Resveratrol

KW - Rictor

UR - http://www.scopus.com/inward/record.url?scp=77949357437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949357437&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvp384

DO - 10.1093/cvr/cvp384

M3 - Article

C2 - 19959541

AN - SCOPUS:77949357437

VL - 86

SP - 103

EP - 112

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 1

ER -